Risk of Pneumonia in Elderly Nursing Home Residents Using Typical Versus Atypical Antipsychotics

Abstract

Spanish

French

BACKGROUND

Antipsychotic medications are extensively used in nursing homes for management of behavioral and psychiatric disorders in the elderly. Prior research suggests that pneumonia is one of the common causes of anti psychotic-related mortality in this population. None of the studies compared typical and atypical antipsychotics with respect to pneumonia.

OBJECTIVE

To examine the risk of pneumonia with use of typical versus atypical antipsychotics in dual eligible elderly nursing home residents.

METHODS

The study involved a retrospective cohort design matched on propensity score using Medicare and Medicaid Analytical eXtract data from 4 US states. The study population included all elderly dual eligible (Medicaid and Medicare) nursing home residents (aged ≥65 years) who initiated antipsychotics any time between July 1, 2001, and December 31, 2003. The risk of pneumonia during the 6-month follow-up period was modeled using a Cox proportional model and extended Cox hazard model stratified on matched pairs based on propensity score, using atypical agents as the reference category.

RESULTS

Analysis of Medicaid-Medicare data revealed that there were 49,904 new antipsychotic (46,293 atypical and 3611 typical) users in the unmatched cohort and 7218 (3609 atypical and 3609 typical) users in the matched cohort. The unadjusted rate of pneumonia was 8.17% (4.61 events per person year) for atypical users and 5.21% (5.21 events per person year) for typical users. The results of Cox regression (average hazard ratio [HR] 1.24; 95% CI 0.94–1.64) and extended regression (<50 days: HR 1.17, 95% CI 0.83–1.66; and 50–180 days: HR 1.36, 95% CI 0.87–2.14) suggest that there was no significant difference in the risk of pneumonia among typical and atypical users.

CONCLUSIONS

The study found no differential risk of pneumonia between typical versus atypical antipsychotic use in dual eligible nursing home residents. Given the differential risk of mortality with typical and atypical antipsychotic use in nursing homes, more research is needed to evaluate other contributory factors of mortality with respect to these 2 antipsychotic classes.

Get full access to this article

View all access options for this article.

References

1. Kamble

, Chen

, Sherer

, Aparasu

. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother 2008; 6: 187–97.

2. Chen

, Briesacher

, Field

, Tjia

, Lau

, Gurwitz

. Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med 2010; 170: 89–95.

3. Carson

, McDonagh

, Peterson

. A systematic review of the efficacy and safety of atypical antipsychotics in patients with psychological and behavioral symptoms of dementia. J Am Geriatr Soc 2006; 54: 354–61.

4. Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. Using antipsychotic agents in older patients. J Clin Psychiatry 2004; 65 (suppl 2): 5–99.

5. Office of Inspector General, Department of Health and Human Services, Medicare Atypical Antipsychotic Drug Claims for Elderly Nursing Home Residents, OEI-07-08-00150 (May 2011), http://oig.hhs.gov/oei/reports/oei-07-08-00150.pdf (accessed 2010 Dec 3).

6. Lieberman

, Stroup

, McEvoy

, et al; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–23.

7. Jones

, Barnes

TRE

, Davies

, Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006; 63: 1079–87.

8. Food and Drug Administration Public Health Advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm053171.htm (accessed 2010 Dec 3).

9. Food and Drug Administration Public Health Advisory. Information for healthcare professionals: conventional antipsychotics. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124830.htm (accessed 2010 Dec 3).

10.

10. Muder

, Brennen

, Swenson

, Wagener

. Pneumonia in a long-term care facility. A prospective study of outcome. Arch Intern Med 1996; 156: 2365–70.

11.

11. Muder

. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med 1998; 105: 319–30.

12.

12. Mylotte

. Nursing home-associated pneumonia. Clin Geriatr Med 2007; 23: 553–65.

13.

13. Mehr

, Binder

, Kruse

, Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI Study. JAMA 2001; 286: 2427–36.

14.

14. Konetzka

, Spector

, Shaffer

. Effects of nursing home ownership type and resident payer source on hospitalization for suspected pneumonia. Med Care 2004; 42: 1001–8.

15.

15. Chan

Carusone S

, Walter

, Brazil

, Loeb

. Pneumonia and lower respiratory infections in nursing home residents: predictors of hospitalization and mortality. J Am Geriatr Soc 2007; 55: 414–9.

16.

16. Loeb

, Mcgeer

, McArthur

, Walter

, Simor

. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999; 159: 2058–64.

17.

17. Quagliarello

, Ginter

, Han

, Van Ness

, Allore

, Tinetti

. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005; 40: 1–6.

18.

18. Trifirò

. Antipsychotic drug use and community-acquired pneumonia. Curr Infect Dis Rep 2011; 13: 262–8.

19.

19. Setoguchi

, Wang

, Brookhart

Alan M

, Canning

, Kaci

, Schneeweiss

. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc 2008; 56: 1644–50.

20.

20. Trifirò

, Gambassi

, Sen

, Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010; 152: 418–25.

21.

21. Knol

, van Marum

, Jansen

. et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008; 56: 661–6.

22.

22. Star

, Bate

, Meyboom

, Edwards

. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? Br J Gen Pract 2010; 60: e385–94.

23.

23. Barnett

, Perry

, Alexander

, Kaboli

. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. J Clin Psychopharmacol 2006; 26: 182–7.

24.

24. Komisar

, Feder

, Kasper

. Unmet long-term care needs: an analysis of Medicare-Medicaid dual eligible. Inquiry 2005,42: 171–82.

25.

25. Aparasu

, Chatterjee

, Mehta

, Chen

. Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents. Med Care 2012; 50: 961–9.

26.

26. Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) general information. http://www.cms.hhs.gov/MedicaidDataSourcesGenInfo/07_MAXGeneralInformation.asp (accessed 2010 Dec 3).

27.

27. Research Data Assistance Center (ResDAC). Available CMS data. http://www.resdac.umn.edu/Available_CMS_Data.asp (accessed 2010 Dec 3).

28.

28. Centers for Medicare & Medicaid Services. Medicare Standard Analytical Files: Identifiable Data Files. http://www.cms.hhs.gov/IdentifiableDataFiles/02_StandardAnalyticalFiles.asp (accessed 2010 Dec 3).

29.

29. Ray

. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003; 158: 915–20.

30.

30. MEPS HC-052 2000 Medical Conditions, June 2003. http://www.meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h52/h52doc.pdf (accessed 2010 Dec 3).

31.

31. Rosenbaum

, Rubin

. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41–55.

32.

32. Brookhart

, Schneeweiss

, Rothman

, Variable selection for propensity score models. Am J Epidemiol 2006; 163: 1149–56.

33.

33. Aparasu

, Jano

, Johnson

, Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother 2008; 6: 198–204.

34.

34. Parson

. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. http://www2.sas.com/proceedings/sugi26/p214-26.pdf (accessed 2010 Dec 3).

35.

35. Austin

. Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score matched analysis. Int J Biostats 2009; 5: 1–21.

36.

36. Alexander

, Kufera

. Butting heads on matched cohort analysis using SAS software. http://www.nesug.org/proceedings/nesug07/sa/sa01.pdf (accessed 2010 Dec 3).

37.

37. Marik

, Kaplan

. Aspiration pneumonia and dysphagia in the elderly. Chest 2003; 124: 328–36.

38.

38. Riquelme

, Torres

, El-Ebiary

, Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med 1996; 154: 1450–5.

39.

39. Stewart

. Reversible dysphagia associated with neuroleptic treatment. J Am Geriatr Soc 2001; 49: 1260–1.

40.

40. Sagar

, Varghese

, Balhara

. Dysphagia due to olanzapine, an antipsychotic medication. Indian J Gastroenterol 2005; 24: 37–8.

41.

41. Nair

, Saeed

, Shahab

, Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect? Gen Hosp Psychiatry 2001; 23: 231–2.

42.

42. Bashford

, Bradd

. Drug-induced parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 1996; 9: 133–5.

43.

43. Wada

, Nakajoh

, Satoh-Nakagawa

, Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology 2001; 47: 271–6.

44.

44. Pierre

. Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management. Drug Saf 2005; 28: 191–208.

45.

45. Jeste

, Rockwell

, Harris

, Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999; 7: 70–6.

46.

46. Miller

. Atypical antipsychotics: sleep, sedation, and efficacy. Prim Car Companion J Clin Psychiatry 2004; 6: 3–7.

47.

47. Venkatesan

, Gladman

, Macfarlane

, A hospital study of community acquired pneumonia in the elderly. Thorax 1990; 45: 254–8.

48.

48. Ozbilen

, Adams

, Marley

. Anticholinergic effects of oral antipsychotic drugs of typicals versus atypicals over medium- and long-term: systematic review and meta-analysis. Curr Med Chem 2012; 19: 5214–8.

49.

49. Guevara

, Butler

, Marston

, Plouffe

, File

Jr , Breiman

. Accuracy of ICD-9-CM codes in detecting community acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999; 149: 282–9.

50.

50. van de Garde

, Oosterheert

, Bonten

, Kaplan

, Leufkens

. International Classification of Diseases Codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007; 60: 834–8